These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38630225)

  • 1. Generation of iPSCs Using Sendai Virus Vectors.
    Aoki H
    Methods Mol Biol; 2024; 2794():121-140. PubMed ID: 38630225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Sendai viral system for reprogramming to naive pluripotency.
    Kunitomi A; Hirohata R; Arreola V; Osawa M; Kato TM; Nomura M; Kawaguchi J; Hara H; Kusano K; Takashima Y; Takahashi K; Fukuda K; Takasu N; Yamanaka S
    Cell Rep Methods; 2022 Nov; 2(11):100317. PubMed ID: 36447645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
    Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
    Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cell line (RCMGi009-A) from urine cells of patient with fibrodysplasia ossificans progressiva.
    Kondrateva E; Grigorieva O; Kurshakova E; Panchuk I; Pozhitnova V; Voronina E; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Aug; 70():103133. PubMed ID: 37307755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Induced Pluripotent Stem Cells from Patients with Multiple Myeloma.
    Yılmaz Başaran İ; Karaöz E
    Turk J Haematol; 2021 Dec; 38(4):254-263. PubMed ID: 33757979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.
    Fujie Y; Fusaki N; Katayama T; Hamasaki M; Soejima Y; Soga M; Ban H; Hasegawa M; Yamashita S; Kimura S; Suzuki S; Matsuzawa T; Akari H; Era T
    PLoS One; 2014; 9(12):e113052. PubMed ID: 25479600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.
    Ban H; Nishishita N; Fusaki N; Tabata T; Saeki K; Shikamura M; Takada N; Inoue M; Hasegawa M; Kawamata S; Nishikawa S
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14234-9. PubMed ID: 21821793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors.
    Tsukamoto M; Kimura K; Yoshida T; Tanaka M; Kuwamura M; Ayabe T; Ishihara G; Watanabe K; Okada M; Iijima M; Nakanishi M; Akutsu H; Sugiura K; Hatoya S
    Stem Cell Reports; 2024 Jan; 19(1):141-157. PubMed ID: 38134923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy and Safety of Sendai Viral Reprograming of Mouse Primary Cells Using Human Vectors.
    Tarnawski L; Eugster E; DeCamp L; Jovinge S
    Cell Reprogram; 2019 Apr; 21(2):78-88. PubMed ID: 30969880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation.
    Kondrateva E; Adilgereeva E; Amelina E; Tabakov V; Demchenko A; Ustinov K; Yasinovsky M; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2020 Oct; 48():101933. PubMed ID: 32777768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Motor Neurons from Human ESCs/iPSCs Using Sendai Virus Vectors.
    Imamura K; Kawaguchi J; Shu T; Inoue H
    Methods Mol Biol; 2021; 2352():127-132. PubMed ID: 34324184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients.
    Baliña-Sánchez C; Aguilera Y; Adán N; Sierra-Párraga JM; Olmedo-Moreno L; Panadero-Morón C; Cabello-Laureano R; Márquez-Vega C; Martín-Montalvo A; Capilla-González V
    Front Immunol; 2023; 14():1022676. PubMed ID: 36776860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture.
    Yamasaki S; Hamada A; Akagi E; Nakatao H; Ohtaka M; Nishimura K; Nakanishi M; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2016 Feb; 52(2):252-64. PubMed ID: 26559068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.
    Seki T; Yuasa S; Fukuda K
    Nat Protoc; 2012 Mar; 7(4):718-28. PubMed ID: 22422317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.